Exhibition

Smartee Strengthens Clinical Engagement in the DACH Region with First GS Summit in Cologne and Presence at TPAO Congress

COLOGNE, Germany, Dec. 12, 2025 /PRNewswire/ -- Smartee Denti-Technology hosted its first GS-focused clinical summit inCologne on November 27, deepening its collaboration with orthodontists across the DACH region. Although Smartee has operated inGermany for more than 2 years through its local sub...

2025-12-12 17:26 1341

COMEUP 2025: Recode the Future --Officially Opens in Seoul from December 10-12

* Korea's largest startup festival, COMEUP 2025, opens on December 10 (KST), bringing together innovative startups, global and domestic investors, and major corporations. * From December 10–12 at COEX Seoul, the three-day event features conferences, exhibitions, IR pitching, business matchmak...

2025-12-12 11:53 1511

Massimo Group to Debut New MVR HVAC Pro Series at the 2026 PGA Show in Orlando, Featuring Fully Enclosed, Climate-Controlled Electric Vehicles

GARLAND, Texas, Dec. 11, 2025 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports and electric vehicles, announced today that it will debut its new MVR HVAC Pro Series at the 2026 PGA Show in Orlando, Florida. This next-generation lineup introduces fully en...

2025-12-11 21:25 1335

HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025

International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors TAIPEI, SHANGHAI, AND SAN FRANCISCO, Dec. 11, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechn...

2025-12-11 21:00 1407

9th Technical Conference of CSCEC Middle East: Redefining Modern Construction with Revolutionary Methods

DUBAI, UAE, Dec. 11, 2025 /PRNewswire/ -- In late October, the 9th Technical Conference, hosted by CSCEC Middle East and co-organized by the Society of Engineers-UAE, was successfully held. Under the theme "Showcasing Revolutionary Modern Methods of Construction to Redefine Tomorrow", this year's...

2025-12-11 16:36 1244

9th Technical Conference of CSCEC Middle East: Redefining Modern Construction with Revolutionary Methods

DUBAI, UAE, Dec. 11, 2025 /PRNewswire/ -- In late October, the 9th Technical Conference, hosted by CSCEC Middle East and co-organized by the Society of Engineers-UAE, was successfully held. Under the theme "Showcasing Revolutionary Modern Methods of Construction to Redefine Tomorrow", this year's...

2025-12-11 14:44 1349

Solace and NetComm Commercialize World's First Wirelessly Powered, Window-Mounted 5G CPE

MOUNT PEARL, NL and SYDNEY, Dec. 11, 2025 /PRNewswire/ -- Solace Power Inc. ("Solace") and NetComm Wireless ("NetComm") today announced a strategic partnership to co-develop and commercialize the world's first wirelessly powered, window-mounted outdoor 5G customer premises equipment (CPE). The p...

2025-12-11 13:00 1213

Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025

HONG KONG, Dec. 10, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific antibody) combined with chemotherapy as a first-line treatment...

2025-12-11 09:53 1133

LG TO SHOWCASE NEXT-GENERATION MOBILITY TECHNOLOGY POWERED BY GENERATIVE AI AT CES 2026

Integrating Advanced AI Models with High-Performance Computing Powered by Snapdragon Cockpit Elite Platform, LG Sets New Standards for the AI-Defined Vehicle Era SEOUL, South Korea, Dec. 10, 2025 /PRNewswire/ -- LG Electronics (LG), a global leader in mobility technologies, is set to unveil its ...

2025-12-11 09:00 1284

WIRobotics to Showcase Wearable Walking-Assist Robot "WIM S" at CES 2026 Unveiled

Three Consecutive CES Innovation Awards Accelerate North American Market Expansion Humanoid Robot ALLEX to Make Its First Global Appearance at CES 2026 SEOUL, South Korea, Dec. 10, 2025 /PRNewswire/ -- WIRobotics, a global robotics technology company, announced that it will present a hands-on d...

2025-12-11 01:00 1124

CES 2026 Reveal: Makalot's StyTrix, Where Decades of Garment Mastery Meet Real-Time AI Innovation

LAS VEGAS and TAIPEI, Dec. 9, 2025 /PRNewswire/ -- Ahead of CES 2026, Makalot Industrial Co., Ltd.  (TWSE#:1477), a leading garment innovator and manufacturer, today announced a major step in its strategic investment in digital transformation. Moving to solidify its r...

2025-12-10 00:03 1221

Neurophet Introduced Use Cases of Its AI-based Brain Imaging Analysis Solutions at the SEACURE Symposium Hosted by Nanyang Technological University in Singapore

* Introduced brain-imaging analysis products, including Neurophet AQUA AD, which enables monitoring of adverse effects related to Alzheimer's disease treatments * Highlighted clinical value of Neurophet AQUA AD…To accelerate efforts across healthcare institutions inSoutheast Asia SEOUL, South...

2025-12-09 22:00 1192

Hyundai Mobis to Unveil 30+ New Technologies at CES 2026, Aiming to Strengthen Global OEM Partnerships

* Hyundai Mobis to participate in CES 2026 next month… hosting an invitation-only private booth to focus on new business opportunities * To be showcased: M.VICS 7.0 cockpit integrated solution, X-by-Wire chassis integrated solution, next-generation displays, and more * "Holographic Windshiel...

2025-12-09 21:00 914

Phase II Data of Cadonilimab Regimen as Neoadjuvant Therapy for Resectable Gastric Cancer Presented at ESMO Asia 2025

HONG KONG, Dec. 9, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that data from the Phase II study (COMPASSION-25) for its first-in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, in combination with SOX regimen (oxaliplatin + tegafur/gimeracil/oteracil) as n...

2025-12-09 15:50 802

Moutai Cultural Exhibition Ignites U.S. Audience with Immersive Journey Through a Century of Cultural Heritage

SAN FRANCISCO, Dec. 8, 2025 /PRNewswire/ -- From December 7 to 8, Kweichow Moutai celebrated a dual milestone - the 110th anniversary of its award-winning debut at the 1915 Panama-Pacific International Exposition and the 10th anniversary of San Francisco Moutai Day - through a dynamic series of e...

2025-12-09 00:13 1002

STRADVISION Announces Next Phase of Cloud-Driven Innovation in Collaboration with AWS

-      Head of Data Innovation Center presents STRADVISION's next roadmap at AWS re:Invent SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- STRADVISION , a global leader in AI-based vision perception technology for vehicles, today announced its forward-looking ...

2025-12-09 00:00 935

Autocrypt Announces Product Release of Post-Quantum PKI Product, Pioneering PQC-enabled Solutions for Automotive OEMs

SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Leading automotive cybersecurity solutions provider AUTOCRYPT announced onDecember 8, 2025, the launch of "AutoCrypt PKI-Vehicles," a new next-generation Public Key Infrastructure (PKI) solution supporting ML-DSA, a post-quantum digital signature ...

2025-12-08 21:00 835

Yantai offers global bay areas a paradigm of low-carbon transformation

YANTAI, China, Dec. 8, 2025 /PRNewswire/ -- On December 4, the 2025 Shandong Green Low-carbon High-quality Development Conference was held in Yantai,Shandong province. Against the backdrop of the fifth anniversary ofChina's 'dual carbon' goals, Yantai's achievements—as one of the country's first ...

2025-12-08 16:52 854

CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting

SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...

2025-12-08 10:08 1038

CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting

SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...

2025-12-08 08:15 884
12345 ... 220

Week's Top Stories